KLHL6 is a tumor suppressor gene in diffuse large B-cell lymphoma

Area of Science:

• Molecular Biology
• Cellular Biology
• Cancer Biology

Background:

• The ubiquitin proteasome system (UPS) is crucial for maintaining cellular homeostasis, and its dysregulation is implicated in various human diseases, notably cancer.
• Kelch-like protein 6 (KLHL6), an E3 ligase, is frequently mutated in diffuse large B-cell lymphoma (DLBCL), suggesting its role in lymphomagenesis.

Purpose of the Study:

• To review the function of KLHL6 as a cullin3-RING ligase.
• To elucidate how cancer-associated mutations affect KLHL6 function and its interaction with cullin3.
• To summarize the tumor-suppressive mechanism of KLHL6 involving Roquin2 degradation and mRNA decay within the NF-κB pathway.

Main Methods:

• Literature review focusing on KLHL6's role in the UPS.
• Analysis of KLHL6 mutations in DLBCL.
• Discussion of KLHL6 substrate identification and pathway analysis.

Main Results:

• KLHL6 functions as a cullin3-RING E3 ligase, and mutations disrupt its interaction with cullin3, leading to loss of function.
• Roquin2 is identified as the first bona fide substrate of KLHL6, critical in B-cell receptor signaling.
• KLHL6-mediated degradation of Roquin2 suppresses tumor growth by regulating mRNA decay and the NF-κB pathway.

Conclusions:

• KLHL6 acts as a tumor suppressor in B-cell lymphomas.
• Understanding KLHL6's mechanism provides insights into DLBCL pathogenesis.
• Targeting the KLHL6-Roquin2 axis may offer therapeutic strategies for B-cell malignancies.